Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001062993-22-004796

Chief Financial Officer gave up 2,829 shares (to pay taxes)

  • Chief Financial Officer acquired 40,348 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Francisco David Chief Financial Officer 2022-02-15 Grant or award +40,348 56,709 D
Francisco David Chief Financial Officer 2022-02-15 Shares withheld for taxes −1,876 $8.03 $15,064 54,833 D
Francisco David Chief Financial Officer 2022-02-16 Shares withheld for taxes −953 $7.78 $7,414 53,880 D
Derivatives
Francisco David Chief Financial Officer 2022-02-15 Grant or award · Stock Option (Right to Buy) +95,692 95,692 D
Loading xslF345X03/form4.xml…